Details
Stereochemistry | RACEMIC |
Molecular Formula | C8H16O2S2 |
Molecular Weight | 208.341 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CCCCC(S)CCS
InChI
InChIKey=IZFHEQBZOYJLPK-UHFFFAOYSA-N
InChI=1S/C8H16O2S2/c9-8(10)4-2-1-3-7(12)5-6-11/h7,11-12H,1-6H2,(H,9,10)
Molecular Formula | C8H16O2S2 |
Molecular Weight | 208.341 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Activity of alpha-lipoic acid in the protection against oxidative stress in skin. | 2001 |
|
Effects of vitamin E and alpha-lipoic acid on skeletal muscle contractile properties. | 2001 Apr |
|
Thiols can either enhance or suppress DNA damage induction by catecholestrogens. | 2001 Jan 1 |
|
Sulfur-centered radical formation from the antioxidant dihydrolipoic acid. | 2001 Nov 16 |
|
alpha-Lipoic acid prevents the development of glucose-induced insulin resistance in 3T3-L1 adipocytes and accelerates the decline in immunoreactive insulin during cell incubation. | 2001 Sep |
|
Modulation of microphthalmia-associated transcription factor gene expression alters skin pigmentation. | 2002 Dec |
|
Avidin: a natural bridge for quantum dot-antibody conjugates. | 2002 Jun 5 |
|
Zinc is a potent inhibitor of thiol oxidoreductase activity and stimulates reactive oxygen species production by lipoamide dehydrogenase. | 2002 Mar 22 |
|
Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis. | 2002 Oct |
|
Preventing superoxide formation in epineurial arterioles of the sciatic nerve from diabetic rats restores endothelium-dependent vasodilation. | 2003 Jan |
|
Reactive oxygen species are involved in the stimulation of the mitochondrial permeability transition by dihydrolipoate. | 2003 Jan 1 |
|
Hemoprotein-mediated reduction of nitrated DNA bases in the presence of reducing agents. | 2003 Jan 15 |
|
Biological and dietary antioxidants protect against DNA nitration induced by reaction of hypochlorous acid with nitrite. | 2003 Jul 1 |
|
Dihydrolipoic acid lowers the redox activity of transition metal ions but does not remove them from the active site of enzymes. | 2004 |
|
Lipoic acid pretreatment attenuates ferric chloride-induced seizures in the rat. | 2004 Aug 6 |
|
Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. | 2004 May |
|
Protein thiol modifications visualized in vivo. | 2004 Nov |
|
Alpha lipoic acid inhibits human T-cell migration: implications for multiple sclerosis. | 2004 Nov 1 |
|
[Lipoic acid: characteristics and therapeutic application]. | 2005 |
|
Fluoroimmunoassays using antibody-conjugated quantum dots. | 2005 |
|
Thermodynamics of the As(III)-thiol interaction: arsenite and monomethylarsenite complexes with glutathione, dihydrolipoic acid, and other thiol ligands. | 2005 Apr 18 |
|
Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. | 2005 Apr 29 |
|
Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children. | 2005 Jun |
|
Inhibition of gelatinase B (matrix metalloproteinase-9) by dihydrolipoic acid. | 2005 Mar |
|
alpha-Lipoic acid induces apoptosis in human colon cancer cells by increasing mitochondrial respiration with a concomitant O2-*-generation. | 2005 Mar |
|
Synthesis of compact multidentate ligands to prepare stable hydrophilic quantum dot fluorophores. | 2005 Mar 23 |
|
Photophysical properties of biologically compatible CdSe quantum dot structures. | 2005 May 26 |
|
Capping of CdSe-ZnS quantum dots with DHLA and subsequent conjugation with proteins. | 2006 |
|
Stimulation of membrane permeability transition by alpha-lipoic acid and its biochemical characteristics. | 2006 |
|
Cellular disulfide-reducing capacity: an integrated measure of cell redox capacity. | 2006 Jun 16 |
|
Size series of small indium arsenide-zinc selenide core-shell nanocrystals and their application to in vivo imaging. | 2006 Mar 1 |
|
Alpha-lipoic acid exhibits anti-amyloidogenicity for beta-amyloid fibrils in vitro. | 2006 Mar 24 |
|
Optical molecular imaging for systems biology: from molecule to organism. | 2006 Oct |
|
Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive external ophthalmoplegia in humans. | 2006 Oct 1 |
|
Effects of lipoic acid and dihydrolipoic acid on 4-aminophenol-mediated erythrocytic toxicity in vitro. | 2006 Sep |
|
Lipoic acid as a novel treatment for Alzheimer's disease and related dementias. | 2007 Jan |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 21:07:41 GMT 2023
by
admin
on
Fri Dec 15 21:07:41 GMT 2023
|
Record UNII |
7NV2KHU5JA
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB03760
Created by
admin on Fri Dec 15 21:07:41 GMT 2023 , Edited by admin on Fri Dec 15 21:07:41 GMT 2023
|
PRIMARY | |||
|
C015144
Created by
admin on Fri Dec 15 21:07:41 GMT 2023 , Edited by admin on Fri Dec 15 21:07:41 GMT 2023
|
PRIMARY | |||
|
7NV2KHU5JA
Created by
admin on Fri Dec 15 21:07:41 GMT 2023 , Edited by admin on Fri Dec 15 21:07:41 GMT 2023
|
PRIMARY | |||
|
DIHYDROLIPOIC ACID
Created by
admin on Fri Dec 15 21:07:41 GMT 2023 , Edited by admin on Fri Dec 15 21:07:41 GMT 2023
|
PRIMARY | |||
|
421
Created by
admin on Fri Dec 15 21:07:41 GMT 2023 , Edited by admin on Fri Dec 15 21:07:41 GMT 2023
|
PRIMARY | |||
|
18047
Created by
admin on Fri Dec 15 21:07:41 GMT 2023 , Edited by admin on Fri Dec 15 21:07:41 GMT 2023
|
PRIMARY | |||
|
DTXSID50861946
Created by
admin on Fri Dec 15 21:07:41 GMT 2023 , Edited by admin on Fri Dec 15 21:07:41 GMT 2023
|
PRIMARY | |||
|
462-20-4
Created by
admin on Fri Dec 15 21:07:41 GMT 2023 , Edited by admin on Fri Dec 15 21:07:41 GMT 2023
|
PRIMARY | |||
|
45230
Created by
admin on Fri Dec 15 21:07:41 GMT 2023 , Edited by admin on Fri Dec 15 21:07:41 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR | |||
|
TARGET -> INHIBITOR |
|
||
|
ENANTIOMER -> RACEMATE | |||
|
TARGET -> INHIBITOR | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |